Product launch in partnership with CMR Surgical

RNS Number : 3419F
Surgical Innovations Group PLC
21 March 2022


Surgical Innovations Group plc

("Surgical Innovations", "SI" or the "Company")


Product launch in partnership with CMR Surgical

Design agreement secured for a new surgical Resposable™ Port Access System


Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), announces the launch of YelloPort™ Elite 5mm, a new surgical Port Access System, developed in partnership with CMR Surgical ('CMR'), a global medical devices company dedicated to transforming surgery with Versius®, a next-generation surgical robot. Under the design agreement Surgical Innovations and CMR have signed, the Company will supply the ResposableTM item for each installed CMR Surgical's Versius Robotic System â .


The new YelloPort Elite™ 5mm product was designed specifically for CMR Surgical's Versius Robotic System â , though it is universal in nature and can be used in combination with a wider range of laparoscopic instrumentation including other robotic systems. The device is designed to function effectively with robotic instrumentation and addresses the continuing need for high-quality cost-effective solutions within laparoscopy surgery, utilising the Company's ResposableTM technology to meet these clinical needs. YelloPort Elite™ 5mm received its CE mark in February 2022 and will be available globally from April 2022.


This is the first project that Surgical Innovations and CMR Surgical, two British-based medical device companies, have collaborated on. Both target international healthcare markets.


Mark Slack, Chief Medical Officer, CMR Surgical, said: "When we talk to hospitals and clinical teams, we hear how important it is for them to reduce the environmental impact of the surgical products and instruments they use. We want to partner with hospitals to reduce waste and cost, whilst advancing performance. Working with Surgical Innovations to develop this new port, for use with our robotic systems, we've been able to do just that."


David Marsh, Chief Executive Officer of Surgical Innovations, said: "We're delighted to partner with CMR Surgical, a fellow British medical device company focused in minimally invasive surgery , to develop this new surgical Port Access System. Our ResposableTM products provide a high-quality hybrid instrument concept, with the clinical benefits of a small disposable element, reducing waste by at least 70% compared to fully disposable alternatives. The project with CMR also creates opportunity to develop greater partnerships in robotic surgery and utilises our existing experience in access devices, instrumentation and flex technology."



For further information please contact:


Surgical Innovations Group plc

www sigroupplc com

David Marsh, CEO

Tel: 0113 230 7597

Charmaine Day, CFO




Singer Capital Markets (Nominated Adviser & Broker)

Tel: 020 7496 3000

Aubrey Powell / Rachel Hayes / Michael Nothnagel




Walbrook PR (Financial PR & Investor Relations)

Tel: 020 7933 8780 or

Paul McManus / Lianne Applegarth

Mob: 07980 541 893 / 07584 391 303



About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity.


We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a "resposable" concept, in which the products are part reusable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives.


Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction.


In addition, we design and develop medical devices for carefully selected OEM partners and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena.


We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs in the operating theatre environment.


Further information

Further details of the Group's businesses and products are available on the following websites:  


To receive regular updates by email, please contact


About CMR Surgical Limited | 

CMR Surgical (CMR) is a global medical devices company dedicated to transforming surgery with Versius®, a next-generation surgical robot.


Headquartered in Cambridge, United Kingdom, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.


Founded in 2014, CMR Surgical is private limited company backed by an international shareholder base.


About the Versius® Surgical Robotic System

Versius® resets expectations of robotic surgery. Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). The small, portable and modular design of Versius allows the surgeon to only use the number of arms needed for a given procedure.


Biomimicking the human arm, Versius gives surgeons the choice of optimised port placement alongside the dexterity and accuracy of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, the open surgeon console has the potential to reduce stress and fatigue and allows for clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that robotic MAS brings.


Versius also captures meaningful data with its wider digital ecosystem to support a surgeon's continuous learning. Through the Versius Connect app, Versius Trainer and CMR clinical registry, the Versius system unleashes can generate a wealth of insights with the ultimate goal of supporting improvements in surgical care.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
UK 100

Latest directors dealings